Christopher Reading

Christopher Reading

Chief Tech/Sci/R&D Officer at
Harbor Therapeutics, Inc.
78 year
Consumer Services
Health Technology
Health Services

Profile

Christopher L.
Reading
is currently the Chief Scientific Officer at Harbor Therapeutics, Inc. He previously held positions as Vice President-Product & Process Development at Systemix, Inc. and Novartis, Inc. He also served as Chief Scientific Officer at Harbor Diversified, Inc. and was an Associate & Assistant Professor at The University of Texas M.D.
Anderson Cancer Center.
Reading holds a doctorate from the University of California, Berkeley and an undergraduate degree from the University of California San Diego.

Christopher Reading active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer 1998-12-31

Former positions of Christopher Reading

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
HARBOR DIVERSIFIED, INC. Chief Tech/Sci/R&D Officer -
See the detail of Christopher Reading's experience

Training of Christopher Reading

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

1

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Christopher Reading